1. Home
  2. XYF vs PEPG Comparison

XYF vs PEPG Comparison

Compare XYF & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo X Financial each representing six

XYF

X Financial each representing six

HOLD

Current Price

$4.82

Market Cap

179.1M

Sector

Finance

ML Signal

HOLD

Logo PepGen Inc.

PEPG

PepGen Inc.

HOLD

Current Price

$2.51

Market Cap

179.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XYF
PEPG
Founded
2014
2018
Country
China
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
179.1M
179.4M
IPO Year
2018
2022

Fundamental Metrics

Financial Performance
Metric
XYF
PEPG
Price
$4.82
$2.51
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
★ $10.19
AVG Volume (30 Days)
47.9K
★ 936.2K
Earning Date
11-19-2026
11-11-2026
Dividend Yield
★ 11.53%
N/A
EPS Growth
N/A
★ 25.61
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.90
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.30
$1.31
52 Week High
$13.16
$7.80

Technical Indicators

Market Signals
Indicator
XYF
PEPG
Relative Strength Index (RSI) 42.21 45.94
Support Level $4.62 $2.24
Resistance Level $5.12 $2.62
Average True Range (ATR) 0.20 0.23
MACD -0.02 0.03
Stochastic Oscillator 14.09 32.20

Price Performance

Historical Comparison
XYF
PEPG

About XYF X Financial each representing six

X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.

About PEPG PepGen Inc.

PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed that their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle, and the central nervous system. Its pipeline products are: PGN-EDO51, PGN-EDODM1, and others.

Share on Social Networks: